| Title |
Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
|
|---|---|
| Published in |
Diabetologia, July 2014
|
| DOI | 10.1007/s00125-014-3305-x |
| Pubmed ID | |
| Authors |
Daniela Jakubowicz, Oren Froy, Bo Ahrén, Mona Boaz, Zohar Landau, Yosefa Bar-Dayan, Tali Ganz, Maayan Barnea, Julio Wainstein |
| Abstract |
Since protein ingestion is known to stimulate the secretion of glucagon-like peptide-1 (GLP-1), we hypothesised that enhancing GLP-1 secretion to harness its insulinotropic/beta cell-stimulating activity with whey protein pre-load may have beneficial glucose-lowering effects in type 2 diabetes. |
X Demographics
The data shown below were collected from the profiles of 86 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 16 | 19% |
| Spain | 7 | 8% |
| United States | 6 | 7% |
| Australia | 2 | 2% |
| United Kingdom | 1 | 1% |
| Argentina | 1 | 1% |
| Canada | 1 | 1% |
| India | 1 | 1% |
| Côte d'Ivoire | 1 | 1% |
| Other | 2 | 2% |
| Unknown | 48 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 75 | 87% |
| Practitioners (doctors, other healthcare professionals) | 8 | 9% |
| Scientists | 3 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| Unknown | 188 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 15% |
| Researcher | 27 | 14% |
| Student > Bachelor | 26 | 14% |
| Student > Ph. D. Student | 23 | 12% |
| Other | 14 | 7% |
| Other | 25 | 13% |
| Unknown | 48 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 23% |
| Agricultural and Biological Sciences | 30 | 16% |
| Nursing and Health Professions | 26 | 14% |
| Biochemistry, Genetics and Molecular Biology | 14 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Other | 15 | 8% |
| Unknown | 54 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 152. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2023.
All research outputs
#273,817
of 25,727,480 outputs
Outputs from Diabetologia
#161
of 5,426 outputs
Outputs of similar age
#2,175
of 241,823 outputs
Outputs of similar age from Diabetologia
#2
of 57 outputs
Altmetric has tracked 25,727,480 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,426 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,823 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.